TSCAN THERAPEUTICS INC (TCRX) Institutional Ownership and Insiders Activity
TSCAN THERAPEUTICS INC (TCRX) is widely held by institutional investors, with 58 firms reporting positions valued at approximately $35.12M based on SEC Form 13F filings for the quarter ended June 30, 2026.
Lynx1 Capital Management Lp is the largest disclosed holder, reporting approximately $7.86M in TCRX holdings in its latest filing.
Recent insider activity includes 2 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.
Institutional Holders
58
Total Reported Value
$35.12M
Largest Holder
Lynx1 Capital Management Lp
Largest Position
$7.86M
Insider Transactions (90d)
2
Latest Filing Quarter
Q2 2026
New Institutional Positions
8
Funds Exiting Positions
7
Top Institutional Owners
View allInvestorReported Balance
- Lynx1 Capital Management Lp$7.86M
- Bvf Inc/Il$5.45M
- Baker Bros. Advisors Lp$2.73M
- Vanguard Capital Management Llc$2.12M
- Two Sigma Investments, Lp$1.91M
Related TCRX Institutional Insights:
- TCRX 13F Institutional Holders
- TCRX Superinvestors
- TCRX Institutional Ownership Changes
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- TCRX Insider Trading & SEC Form 4 Activity
- TCRX Articles
- Top Institutional Investor Stock Rankings